A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Board meeting of ads diagnostic ....
Awaiting price reaction for this filing.
A D S Diagnostics Ltd has informed BSE that its Board of Directors will meet on Friday, 13 February 2026 at the registered office in New Delhi. The main agenda is to consider and approve the Unaudited Financial Results for the quarter ended 31 December 2025 (Q3 FY26). The notice also includes a standard provision to transact any other business placed before the Board with the Chairman's permission. The filing was signed by the CFO & Company Secretary and is submitted under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements.
This is a routine advance notice with no financial numbers disclosed yet. Investors should watch for the actual Q3 results announcement on or shortly after 13 February 2026 for any meaningful impact on the stock.